ERBB2 and breast carcinoma: Breast cancer is a genetically and clinically heterogeneous disease that is clinically classified into four subtypes by the expression of receptors, such as the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).